Maxcyte.
103 announcements.
103 announcements.
Time | Date | Ticker | Company | Announcement |
---|---|---|---|---|
17:09 | 02-12-2024 | MXCT | Maxcyte | Total Voting Rights and Block Listing Return |
15:05 | 28-11-2024 | MXCT | Maxcyte | Holding(s) in Company |
15:05 | 28-11-2024 | MXCT | Maxcyte | Holding(s) in Company |
09:49 | 19-11-2024 | MXCT | Maxcyte | Holding(s) in Company |
07:00 | 07-11-2024 | MXCT | Maxcyte | Third Quarter 2024 Financial Results |
13:43 | 06-11-2024 | MXCT | Maxcyte | Exercise of options and PDMR dealing |
13:23 | 04-11-2024 | MXCT | Maxcyte | Total Voting Rights |
07:00 | 31-10-2024 | MXCT | Maxcyte | Exercise of options and PDMR dealing |
09:24 | 18-10-2024 | MXCT | Maxcyte | Grant of Options and Restricted Stock Units |
13:05 | 15-10-2024 | MXCT | Maxcyte | MaxCyte Appoints Cynthia Collins to Board |
13:00 | 11-10-2024 | MXCT | Maxcyte | Notice of Results |
13:05 | 10-10-2024 | MXCT | Maxcyte | MaxCyte Appoints Ali Soleymannezhad as CCO |
09:41 | 03-10-2024 | MXCT | Maxcyte | Exercise of options and PDMR dealing |
09:47 | 01-10-2024 | MXCT | Maxcyte | Exercise of options and PDMR dealing |
07:00 | 01-10-2024 | MXCT | Maxcyte | Total Voting Rights |
16:15 | 27-09-2024 | MXCT | Maxcyte | Holding(s) in Company |
15:29 | 27-09-2024 | MXCT | Maxcyte | Holding(s) in Company |
17:02 | 20-09-2024 | MXCT | Maxcyte | Holding(s) in Company |
07:00 | 16-09-2024 | MXCT | Maxcyte | TR-1: Notification of major holdings |
17:07 | 06-09-2024 | MXCT | Maxcyte | Exercise of options and PDMR dealing |
15:38 | 03-09-2024 | MXCT | Maxcyte | Total Voting Rights |
10:06 | 29-08-2024 | MXCT | Maxcyte | Exercise of options and PDMR dealing |
07:00 | 07-08-2024 | MXCT | Maxcyte | Second Quarter and Half-Year Results |
16:31 | 01-08-2024 | MXCT | Maxcyte | Total Voting Rights |
07:00 | 31-07-2024 | MXCT | Maxcyte | Exercise of options and PDMR dealing |
09:15 | 10-07-2024 | MXCT | Maxcyte | Notice of Results |
09:14 | 09-07-2024 | MXCT | Maxcyte | Change of Name of Nominated Adviser and Broker |
07:00 | 03-07-2024 | MXCT | Maxcyte | TR-1: Notification of major holdings |
11:18 | 02-07-2024 | MXCT | Maxcyte | Exercise of options and PDMR dealing |
07:00 | 02-07-2024 | MXCT | Maxcyte | Total Voting Rights |
14:34 | 27-06-2024 | MXCT | Maxcyte | Publication of Annual Report |
07:00 | 14-06-2024 | MXCT | Maxcyte | Grant of Options and Restricted Stock Units |
07:00 | 12-06-2024 | MXCT | Maxcyte | Result of AGM |
07:00 | 11-06-2024 | MXCT | Maxcyte | PDMR Dealing |
15:22 | 03-06-2024 | MXCT | Maxcyte | Total Voting Rights |
13:05 | 29-05-2024 | MXCT | Maxcyte | Participation in Upcoming Investor Conference |
14:55 | 14-05-2024 | MXCT | Maxcyte | Holding(s) in Company |
07:00 | 08-05-2024 | MXCT | Maxcyte | First Quarter Results |
07:00 | 03-05-2024 | MXCT | Maxcyte | Notice of AGM |
17:04 | 01-05-2024 | MXCT | Maxcyte | Total Voting Rights |
13:05 | 10-04-2024 | MXCT | Maxcyte | Notice of Results |
07:00 | 03-04-2024 | MXCT | Maxcyte | Total Voting Rights and Block Listing Return |
07:00 | 02-04-2024 | MXCT | Maxcyte | Exercise of options and PDMR dealing |
10:05 | 20-03-2024 | MXCT | Maxcyte | Grant of Options, RSUs and PSUs and PDMR Dealing |
10:16 | 20-03-2024 | MXCT | Maxcyte | Grant of Options, RSUs and PSUs and PDMR Dealing |
07:00 | 13-03-2024 | MXCT | Maxcyte | Reports Q4 & FY 2023 Financial Results |
08:58 | 06-03-2024 | MXCT | Maxcyte | TR-1: Notification of major holdings |
07:00 | 05-03-2024 | MXCT | Maxcyte | Preliminary FY Results & 2024 Guidance |
09:21 | 29-02-2024 | MXCT | Maxcyte | Exercise of options and PDMR dealing |
07:00 | 26-02-2024 | MXCT | Maxcyte | TR-1: Notification of major holdings |
13:05 | 09-02-2024 | MXCT | Maxcyte | Notice of Results |
09:24 | 01-02-2024 | MXCT | Maxcyte | Total Voting Rights |
07:00 | 31-01-2024 | MXCT | Maxcyte | Director/PDMR Shareholding |
14:29 | 30-01-2024 | MXCT | Maxcyte | Holding(s) in Company |
16:52 | 29-01-2024 | MXCT | Maxcyte | TR-1: Notification of major holdings |
07:00 | 09-01-2024 | MXCT | Maxcyte | Preliminary Unaudited Q4 and FY 2023 Results |
07:00 | 05-01-2024 | MXCT | Maxcyte | Grant of Options and PDMR Dealing |
09:23 | 02-01-2024 | MXCT | Maxcyte | Total Voting Rights |
07:00 | 02-01-2024 | MXCT | Maxcyte | Confirmation of Board change |
07:00 | 29-12-2023 | MXCT | Maxcyte | Exercise of options and PDMR dealing |
07:00 | 12-12-2023 | MXCT | Maxcyte | CEO Transition and Revenue Guidance Update |
09:50 | 07-12-2023 | MXCT | Maxcyte | Exercise of options and PDMR dealing |
07:00 | 04-12-2023 | MXCT | Maxcyte | Exercise of options and PDMR dealing |
17:43 | 01-12-2023 | MXCT | Maxcyte | Total Voting Rights |
07:00 | 30-11-2023 | MXCT | Maxcyte | Exercise of options and PDMR dealing |
07:00 | 17-11-2023 | MXCT | Maxcyte | Exercise of options and PDMR dealing |
07:00 | 09-11-2023 | MXCT | Maxcyte | Third Quarter Results |
07:00 | 07-11-2023 | MXCT | Maxcyte | Participation in Upcoming Investor Conferences |
13:12 | 01-11-2023 | MXCT | Maxcyte | Total Voting Rights |
07:00 | 05-10-2023 | MXCT | Maxcyte | Preliminary Q3 Revenue & FY Revenue Guidance |
16:03 | 02-10-2023 | MXCT | Maxcyte | Total Voting Rights |
14:28 | 13-09-2023 | MXCT | Maxcyte | TR-1: Notification of major holdings |
13:21 | 12-09-2023 | MXCT | Maxcyte | TR-1: Notification of major holdings |
16:17 | 05-09-2023 | MXCT | Maxcyte | TR-1: Notification of major holdings |
13:05 | 05-09-2023 | MXCT | Maxcyte | Baird Global Healthcare Conference Participation |
13:32 | 04-09-2023 | MXCT | Maxcyte | TR-1: Notification of major holdings |
07:00 | 04-09-2023 | MXCT | Maxcyte | Total Voting Rights |
09:01 | 01-09-2023 | MXCT | Maxcyte | Exercise of options and PDMR dealing |
17:25 | 18-08-2023 | MXCT | Maxcyte | TR-1 |
16:27 | 17-08-2023 | MXCT | Maxcyte | TR-1: Notification of major holdings |
07:00 | 17-08-2023 | MXCT | Maxcyte | TR-1: Notification of Major Holdings |
07:00 | 10-08-2023 | MXCT | Maxcyte | Second Quarter and Half-Year Results |
15:15 | 08-08-2023 | MXCT | Maxcyte | TR-1: Notification of major holdings |
17:01 | 07-08-2023 | MXCT | Maxcyte | Total Voting Rights and Block Listing Return |
14:31 | 26-07-2023 | MXCT | Maxcyte | TR-1: Notification of major holdings |
17:08 | 24-07-2023 | MXCT | Maxcyte | TR-1: Notification of major holdings |
17:06 | 24-07-2023 | MXCT | Maxcyte | TR-1: Notification of major holdings |
13:05 | 13-07-2023 | MXCT | Maxcyte | Notice of Second Quarter 2023 Financial Results |
07:00 | 11-07-2023 | MXCT | Maxcyte | TR-1: Notification of major holdings |
07:00 | 10-07-2023 | MXCT | Maxcyte | TR-1: Notification of major holdings |
09:23 | 07-07-2023 | MXCT | Maxcyte | Total Voting Rights |
15:19 | 29-06-2023 | MXCT | Maxcyte | TR-1: Notification of major holdings |
07:00 | 29-06-2023 | MXCT | Maxcyte | TR-1: Notification of major holdings |
07:00 | 29-06-2023 | MXCT | Maxcyte | Exercise of options and PDMR dealing |
15:46 | 23-06-2023 | MXCT | Maxcyte | Grant of Options |
07:17 | 23-06-2023 | MXCT | Maxcyte | Result of AGM |
07:00 | 23-06-2023 | MXCT | Maxcyte | Result of AGM |
10:10 | 21-06-2023 | MXCT | Maxcyte | Publication of Annual Report |
12:32 | 16-06-2023 | MXCT | Maxcyte | Exercise of options and PDMR dealing |
07:00 | 02-06-2023 | MXCT | Maxcyte | Upcoming Investor Conferences |
07:00 | 01-06-2023 | MXCT | Maxcyte | Total Voting Rights |
07:00 | 11-05-2023 | MXCT | Maxcyte | First Quarter Financial Results |
07:00 | 09-05-2023 | MXCT | Maxcyte | Exercise of options and PDMR dealing |